Loading...
Market
Will Lecanemab be prescribed privately in the UK by March 31, 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Reports from major UK healthcare providers or pharmacies
Story
Alzheimer's Wonder Drug Lecanemab, Biggest Breakthrough in Decades, Set for UK Approval
Aug 21, 2024, 11:46 PM
The Alzheimer's wonder drug Lecanemab is set to receive approval for use in Britain, marking a significant advancement in the treatment of the disease. This drug is the first to demonstrate the ability to slow down the progression of Alzheimer's, offering new hope to patients and healthcare providers. The approval is expected to allow Lecanemab to be prescribed privately, with potential for future availability through the National Health Service (NHS). The Medicines and Healthcare products Regulatory Agency (MHRA) is anticipated to make a favorable decision soon. While not a cure, Lecanemab represents a crucial step forward in Alzheimer's treatment, highlighting the need for increased investment in dementia services and early diagnosis. Described as the biggest breakthrough in decades, this development underscores the importance of continued research and support for Alzheimer's patients.
View original story
Similar markets
Less than 500 • 25%
500 to 1000 • 25%
1001 to 2000 • 25%
More than 2000 • 25%
Yes • 50%
No • 50%
Less than £1000 • 25%
£1000 to £2000 • 25%
£2001 to £3000 • 25%
More than £3000 • 25%
Yes • 50%
No • 50%
Approved for preventive use • 25%
Approved with restrictions • 25%
Rejected • 25%
No decision • 25%